Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Moderna a Long-Term Buy?

TheMotleyFool

0 0

Investors flocked to Moderna (NASDAQ: MRNA) last year with hopes its coronavirus vaccine program would bear fruit. Since, the company has become one of the first to commercialize a coronavirus vaccine. But Moderna's growth story isn't over. In this Motley Fool Live video recorded on Jan. 22, 2021, healthcare and cannabis bureau chief Corinne Cardina and Fool.com contributor Adria Cimino discuss the elements that could push Moderna shares higher over the long term.

Source Fool.com

Like: 0

MRNA

Share